Showing results (121-130 of 841) with videos related to
Sort By:
Pageof 85
International Journal of Clinical Oncology|October 18, 2011
Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: AVASIRI trialYosuke Horita, Yasuhide Yamada, Ken Kato, et al.Anticancer Research|May 7, 2013
KRAS mutations in patients with colorectal cancer as detected by high-resolution melting analysis and direct sequencingKohei Akiyoshi, Yasuhide Yamada, Yoshitaka Honma, et al.Journal of Cancer Research and Clinical Oncology|October 17, 2013
Impact of adding cisplatin to S-1 in elderly patients with advanced gastric cancerTetsuji Terazawa, Satoru Iwasa, Atsuo Takashima, et al.Japanese Journal of Clinical Oncology|April 7, 2011
A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC)Atsuo Takashima, Yasuhiro Shimada, Tetsuya Hamaguchi, et al.International Journal of Clinical Oncology|December 10, 2003
Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancerYasuhide Yamada, Hisateru Yasui, Ayumu Goto, et al.International Journal of Clinical Oncology|November 19, 2004
Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracilAyumu Hosokawa, Yasuhide Yamada, Yasuhiro Shimada, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 24, 2004
Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1, an oral fluoropyrimidine derivative, as single-agent chemotherapyKan Yonemori, Yasuhiro Shimada, Ayumu Goto, et al.Cancer Science|June 17, 2005
High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal modelHiroyuki Tsuda, Katsumi Fukamachi, Yutaka Ohshima, et al.International Journal of Clinical Oncology|January 12, 2012
Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trialToshihiko Doi, Tetsuya Hamaguchi, Kuniaki Shirao, et al.Anticancer Research|April 3, 2014
Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectal cancer in Japanese patientsYusuke Sasaki, Tetsuya Hamaguchi, Tatsuhiro Arai, et al.Pageof 85